Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,262 | 171 | 93.3% |
| Education | $304.20 | 4 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $571.14 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $399.85 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $389.85 | 10 | $0 (2024) |
| ABBVIE INC. | $267.47 | 10 | $0 (2024) |
| Genentech USA, Inc. | $248.18 | 8 | $0 (2024) |
| Incyte Corporation | $219.41 | 3 | $0 (2024) |
| Seagen Inc. | $210.63 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $206.72 | 11 | $0 (2024) |
| Genmab U.S., Inc. | $174.89 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $154.15 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,047 | 50 | ABBVIE INC. ($267.47) |
| 2023 | $2,109 | 87 | Daiichi Sankyo Inc. ($250.05) |
| 2022 | $1,110 | 34 | AstraZeneca Pharmaceuticals LP ($300.60) |
| 2021 | $300.48 | 4 | Incyte Corporation ($124.39) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immunology | ||||||
| 03/01/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: BioOncology | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Rare Disease | ||||||
| 02/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | Genentech, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $68.74 | General |
| Category: BioOncology | ||||||
| 02/05/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Oncology | ||||||
| 02/02/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Hematology | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: ONCOLOGY | ||||||
| 01/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Rare Disease | ||||||
| 01/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Immunology | ||||||
| 01/22/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Oncology | ||||||
| 01/18/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Hematology | ||||||
| 01/17/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Immunology | ||||||
| 01/12/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Rare Disease | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Oncology | ||||||
| 01/09/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Oncology | ||||||
| 01/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Oncology | ||||||
About Dr. Frankie Powell, MD
Dr. Frankie Powell, MD is a Hematology & Oncology healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1780175554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frankie Powell, MD has received a total of $4,566 in payments from pharmaceutical and medical device companies, with $1,047 received in 2024. These payments were reported across 175 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($4,262).
Practice Information
- Specialty Hematology & Oncology
- Location Newport News, VA
- Active Since 05/28/2018
- Last Updated 11/12/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780175554
Products in Payments
- IMBRUVICA (Drug) $278.45
- Enhertu (Drug) $253.52
- LYNPARZA (Drug) $250.00
- ADCETRIS (Biological) $226.48
- MONJUVI (Drug) $219.41
- EPKINLY (Drug) $199.52
- KEYTRUDA (Biological) $190.13
- INJECTAFER (Drug) $168.58
- Tivdak (Drug) $153.60
- ENHERTU (Drug) $149.04
- PROMACTA (Drug) $148.79
- Tecentriq (Biological) $148.41
- ZEJULA (Drug) $134.58
- Fabhalta (Drug) $122.05
- DARZALEX (Biological) $120.17
- Lenvima (Drug) $117.87
- OPDIVO (Biological) $109.30
- ENHERTU (Biological) $84.58
- XPOVIO (Drug) $71.89
- Columvi (Biological) $68.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Newport News
David Chang, M.d., Phd, M.D., PHD
Hematology & Oncology — Payments: $84,986
Bruce Booth, Md, MD
Hematology & Oncology — Payments: $21,024
Dr. Ligeng Tian, B.m, B.M
Hematology & Oncology — Payments: $4,095
Mashour Yousef, M.d, M.D
Hematology & Oncology — Payments: $815.18
Flavia Kostov, M.d, M.D
Hematology & Oncology — Payments: $470.43
Vihitha Thota, Md, MD
Hematology & Oncology — Payments: $236.43